Enterome’s GeneMark-HM software highlighted as the most accurate microbiome gene prediction software in peer-reviewed publication NAR Genomics and Bioinformatics

PARIS, June 16, 2021 /PRNewswire/ — ENTEROME SA, a clinical stage biopharmaceutical company developing novel drugs based on its unique ability to de-code the molecular interactions in the gut microbiome impacting human health, announces that the powerful capabilities of its proprietary…

About the Author

has written 41789 stories on this site.

Copyright © 2010 Business and Corporate News.